Oxford and GSK launch £50m programme to advance cancer research
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
Read moreLatest News
Upcoming Talks
Heralding Intelligent cancer vaccines- designed with AI, improving like ChatGPT, tested then manufactured with robotics, and printed at sites
Wednesday, 29 July 2026, 12pm to 1pm
From the Laboratory to the Clinic 2026: Complex pathogenesis of disease
Tuesday, 01 September 2026 to Friday, 04 September 2026, 9am - 6pm
Latest publications
Glycodeoxycholic and deoxycholic bile acids impair recognition and spatial memory in adult mice, and reduce central CREB-BDNF signaling and cytokine expression with neuroanatomical specificity.
Journal article
Garcia A. et al, (2026), Gut Microbes, 18
DNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
The double-edged nature of antibody bivalency: mathematical and experimental analysis of cell surface antigen occupancy and opsonization.
Journal article
Heirene L. et al, (2026), MAbs, 18
Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization.
Journal article
van Niekerk L. et al, (2026), MAbs, 18